Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF

• Claire Ward,

  Affiliation Drug Discovery, Fusion Antibodies Ltd, Belfast, United Kingdom

  ⨯
• Diana Kuehn,

  Affiliation Drug Discovery, Fusion Antibodies Ltd, Belfast, United Kingdom

  ⨯
• Roberta E. Burden,

  Affiliations Drug Discovery, Fusion Antibodies Ltd, Belfast, United Kingdom, School of Pharmacy, Queens University Belfast, Belfast, United Kingdom

  ⨯
• Julie A. Gormley,

  Affiliation Drug Discovery, Fusion Antibodies Ltd, Belfast, United Kingdom

  ⨯
• Thomas J. Jaquin,

  Affiliation Drug Discovery, Fusion Antibodies Ltd, Belfast, United Kingdom

  ⨯
• Mihaela Gazdoiu,

  Affiliation Drug Discovery, Fusion Antibodies Ltd, Belfast, United Kingdom

  ⨯
• Donna Small,

  Affiliations Drug Discovery, Fusion Antibodies Ltd, Belfast, United Kingdom, School of Pharmacy, Queens University Belfast, Belfast, United Kingdom

  ⨯
• Roy Bicknell,

  Affiliation Schools of Immunity and Infection and Cancer Studies, College of Medicine and Dentistry, University of Birmingham, Birmingham, United Kingdom

  ⨯
• James A. Johnston,

  Affiliation Centre for Infection and Immunity, Queens University Belfast, Belfast, United Kingdom

  ⨯
• Christopher J. Scott ,

  * E-mail: c.scott@qub.ac.uk (CJS); shane.olwill@fusionantibodies.com (SAW)

  Affiliation School of Pharmacy, Queens University Belfast, Belfast, United Kingdom

  ⨯
• Shane A. Olwill

  * E-mail: c.scott@qub.ac.uk (CJS); shane.olwill@fusionantibodies.com (SAW)

  Affiliation Drug Discovery, Fusion Antibodies Ltd, Belfast, United Kingdom

  ⨯